Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants [Phase 1]
Phase 1 study evaluating the drug interaction between BAY2927088 and Midazolam, assessing whether BAY2927088 alters Midazolam exposure when …
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study [Phase 3]
Phase 3 investigator-initiated randomized trial in EGFR-mutated non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC [Phase 3]
A Phase 3 prospective cohort study is evaluating neoadjuvant chemotherapy plus Sintillumab for resectable non-small cell lung cancer. The tr…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients [NA]
A clinical trial update for NCT04222335 sponsored by University Hospital, Toulouse, currently recruiting to study early adaptive resistance …
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
This clinical trial is investigating real-world outcomes of non-small cell lung cancer patients treated with neoadjuvant immunotherapy, aimi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II [Phase 2]
Phase II ORIGIN trial (SAKK 17/18) evaluating first-line gemcitabine with atezolizumab in malignant pleural mesothelioma and non-small cell …
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PRT3645 conducted by Prelude Therapeutics in patients with several advanced solid tumors has completed, including breast …
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC
This clinical trial investigates single-cell biomarkers to predict efficacy and toxicity of immune checkpoint inhibitors in non-small cell l…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib
A clinical study is recruiting to evaluate local ablative therapy for oligoprogressive non-small cell lung cancer in patients receiving firs…
-
CLINICAL_TRIALS other · 2024-07-01Clinical Trial Update: ETERNALS: Remote Monitoring in Lung Cancer Patients [NA]
Clinical trial ETERNALS is not yet recruiting and targets remote monitoring in non-small cell lung cancer patients.
-
FDA approval · 2024-06-28FDA Approved: AXTLE — Original Application (Avyxa Pharma, LLC)
FDA approved the original application for AXTLE (pemetrexed) by Avyxa Pharma, LLC, for treatment of malignant pleural mesothelioma and non-s…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases [Phase 2]
Phase 2 clinical trial update evaluating the combination of radiosurgery and nivolumab for brain metastases in various cancers, with complet…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone [Phase 1, Phase 2]
A Phase 1/2 study comparing gefitinib with olaparib versus gefitinib alone in non-small cell lung cancer has completed, and results have bee…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations [Phase 2]
Phase 2 clinical trial update for a targeted therapy in incurable non-small cell lung cancer with EGFR mutations; the study was terminated a…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: SHR-A1921 Combined With Adebrelimab in the Treatment of Advanced NSCLC Who Failed the Previous Standard First-line Treatment [Phase 2]
Phase 2 clinical trial investigating SHR-A1921 combined with adebrelimab for advanced non-small cell lung cancer in patients who failed prio…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO) [Phase 2]
Phase 2 trial evaluating osimertinib with Locally Ablative Radiotherapy in patients with synchronous oligo-metastatic EGFR-mutant non-small …
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
A clinical study evaluating the role and impact of wearable smart devices for perioperative care in patients with non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: LM-108 Antibody Combination With Sintilimab for Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating LM-108 antibody in combination with sintilimab for locally advanced or metastatic non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: TGRX-326 Pharmacokinetic Drug Interaction [Phase 1]
Phase 1 pharmacokinetic drug interaction study of TGRX-326 in Non-Small Cell Lung Cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Cios Mobile 3D Spin for Robotic Bronchoscopy
Clinical trial update indicates the Mayo Clinic-sponsored study evaluating the Cios Mobile 3D Spin for robotic bronchoscopy has completed. T…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: PPIO-006 Primary Tumor Resection for IVa NSCLC
A clinical trial update confirms the completion of NCT06232967, evaluating primary tumor resection for stage IVa non-small cell lung cancer,…
-
CLINICAL_TRIALS other · 2024-06-27Clinical Trial Update: AN0025 and Pembrolizumab Combination in Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update announcing AN0025 in combination with pembrolizumab for advanced solid tumors; the study includes several indi…
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer
A clinical trial update describing an active-not-recruiting study from Ruijin Hospital evaluating radical surgery in patients with early-sta…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 study evaluating anamorelin HCl for malignancy-associated weight loss and anorexia in adults with advanced non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating anamorelin hydrochloride for malignancy-associated weight loss and anorexia in adults with advanced non-small cell …